NuraLogix introduces well being measurement app in Singapore
Canadian well being AI firm NuraLogix has launched its cell well being measurement app in Singapore.
Anura makes use of proprietary transdermal optical imaging expertise, which captures blood data from an individual’s face by means of a video digicam. It will probably measure varied important parameters, together with blood strain, coronary heart fee, stress degree, cardiac workload, and danger of coronary heart assault and stroke.
The facial blood movement information is then processed by way of cloud the place an AI engine known as DeepAffex applies superior sign processing and deep studying to foretell physiological and psychological impacts.
The studying course of, in keeping with the corporate, takes solely 30 seconds.
AI drug discovery agency Standigm companions with Merck Korea
Standigm, an AI drug discovery firm in South Korea, has signed a memorandum of understanding with life science agency Merck Korea for AI-driven drug discovery analysis.
Primarily based on a media launch, the partnership entails Standigm’s adoption of Merck’s AI software program SYNTHIA for compound synthesis.
SYNTHIA is a computer-aided retrosynthetic design instrument that may shortly design artificial pathways.
“Making use of AI to the drug discovery course of can dramatically scale back time in discovering novel drug candidates and discovering optimised synthesis paths,” mentioned Standigm CEO and co-founder Sojeong Yun.
Late final yr, Standigm formalised a partnership with Institut Pasteur Korea for growing new anti-tubercular drug candidates by means of AI.
Nalagenetics will get CE mark for its pharmacogenomics software program
Singaporean biotechnology agency Nalagenetics has obtained a CE mark for its pharmacogenomics software program.
The PGx Core module on its Nala Medical Determination Help software program goes with its Nala PGx Core(R) pharmacogenomics testing package, which genotypes lead pharmacogenes.
In accordance with a press assertion, each merchandise are used collectively as a plug-and-play resolution for labs with qPCR machines.
The qPCR testing package can learn 20 variants inside 4 recognized pharmacogenes, CYP2D6, CYP2C9, CYP2C19, and SLCO1B1, whereas the software program can generate greater than 170 drug-gene reviews.
In recent times, qPCR testing has been broadly adopted for COVID-19 testing.
“With pharmacogenomics testing changing into increasingly ubiquitous around the globe, it requires standardised and sturdy instruments to help the speedy enhance of adoption,” mentioned Nalagenetics CEO Levana Sani.